Home > Qtrly Results > BAL PHARMA

BAL PHARMA
Quarterly Results Analysis [Sep2025]

AD     Remove this Ad

BAL PHARMA Quarterly Results

Consolidated Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
Audited
Revenues ₹74 Cr ₹66 Cr ₹82 Cr ₹73 Cr ₹74 Cr ₹74 Cr ₹95 Cr ₹82 Cr
Expenses ₹68 Cr ₹60 Cr ₹74 Cr ₹65 Cr ₹66 Cr ₹68 Cr ₹85 Cr ₹74 Cr
Operating Income ₹6 Cr ₹6 Cr ₹8 Cr ₹8 Cr ₹8 Cr ₹6 Cr ₹10 Cr ₹8 Cr
Other Income ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹2 Cr ₹0 Cr
Interest ₹4 Cr ₹4 Cr ₹4 Cr ₹5 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr
Depreciation ₹2 Cr ₹3 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹3 Cr
Profit Before Tax ₹1 Cr ₹0 Cr ₹3 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹6 Cr ₹1 Cr
Profit After Tax ₹1 Cr ₹0 Cr ₹5 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹6 Cr ₹1 Cr
EPS ₹0.45 ₹0.13 ₹3.41 ₹0.30 ₹0.65 ₹0.16 ₹3.46 ₹0.56
Industry Peers & Returns1W1M1Y
BAL PHARMA -1.4% -0.1% -35.2%
SUN PHARMACEUTICAL INDUSTRIES 0.5% -1.5% -2.6%
DIVIS LABORATORIES 5.5% -0.2% 0.8%
CIPLA 1.3% -7.9% -6.6%
TORRENT PHARMACEUTICALS 2.1% 2.8% 30.9%
DR REDDYS LABORATORIES 2% 4.5% 2.3%
MANKIND PHARMA 0.2% -6.3% -16.6%
ZYDUS LIFESCIENCES -0.8% 0.3% -9.3%
LUPIN -0.4% 0.9% 0.8%

BAL PHARMA Quarterly Revenues

Revenues
Q-o-Q

12.38 %

Y-o-Y

0.45 %

Quarters Revenues % Change
Sep2025 ₹74 Cr
12.38
Jun2025 ₹66 Cr
-19.55
Mar2025 ₹82 Cr
11.92
Dec2024 ₹73 Cr
-0.73
Sep2024 ₹74 Cr
-0.89
Jun2024 ₹74 Cr
-21.42
Mar2024 ₹95 Cr
15.87
Dec2023 ₹82 Cr -

BAL PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-5.45 %

Y-o-Y

-25.54 %

Quarters Operating Profit % Change
Sep2025 ₹6 Cr
-5.45
Jun2025 ₹6 Cr
-20.69
Mar2025 ₹8 Cr
-1.51
Dec2024 ₹8 Cr
0.82
Sep2024 ₹8 Cr
19.03
Jun2024 ₹6 Cr
-32.60
Mar2024 ₹10 Cr
23.05
Dec2023 ₹8 Cr -
Operating Margins
Q-o-Q

-15.87 %

Y-o-Y

-25.86 %

Quarters Operating Margin% % Change
Sep2025 7.74%
-15.87
Jun2025 9.2%
-1.39
Mar2025 9.33%
-12.06
Dec2024 10.61%
1.63
Sep2024 10.44%
20.14
Jun2024 8.69%
-14.30
Mar2024 10.14%
6.18
Dec2023 9.55% -

BAL PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

243.06 %

Y-o-Y

-31.06 %

Quarters Profit After Tax % Change
Sep2025 ₹1 Cr
243.06
Jun2025 ₹0 Cr
-96.14
Mar2025 ₹5 Cr
944.12
Dec2024 ₹1 Cr
-50.10
Sep2024 ₹1 Cr
301.54
Jun2024 ₹0 Cr
-95.32
Mar2024 ₹6 Cr
551.59
Dec2023 ₹1 Cr -
PAT Margins
Q-o-Q

203.13 %

Y-o-Y

-31.21 %

Quarters PAT Margin(%) % Change
Sep2025 0.97 %
203.13
Jun2025 0.32 %
-95.17
Mar2025 6.62 %
832.39
Dec2024 0.71 %
-49.65
Sep2024 1.41 %
302.86
Jun2024 0.35 %
-94.02
Mar2024 5.85 %
462.50
Dec2023 1.04 % -

BAL PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

246.15 %

Y-o-Y

-30.77 %

Quarters EPS % Change
Sep2025 ₹0.45
246.15
Jun2025 ₹0.13
-96.19
Mar2025 ₹3.41
1,036.67
Dec2024 ₹0.3
-53.85
Sep2024 ₹0.65
306.25
Jun2024 ₹0.16
-95.38
Mar2024 ₹3.46
517.86
Dec2023 ₹0.56 -

You may also like the below Video Courses